Press Releases

Press Releases

  1. BTG plc: FDA approves Varithena™ (polidocanol injectable foam) for the treatment of patients with varicose veins

  2. BTG to present at Jefferies Global Healthcare Conference

  3. BTG plc: Interim Results

  4. BTG plc: Notification of Results

  5. BTG plc: Close Period Update

  6. BTG plc: European Commission Approves Multiple Sclerosis Treatment Lemtrada™ (alemtuzumab)

  7. BTG sells brachytherapy business to Eckert & Ziegler

  8. BTG plc: TheraSphere® Recommended by the National Institute for Health and Care Excellence (NICE) for the Treatment of Primary and Secondary Liver Cancer

  9. BTG plc: Positive Results from VANISH-2 Study Data Published in the Journal Phlebology

  10. BTG plc: Interim Management Statement

  11. BTG plc: Completion of the Acquisition of TheraSphere®

  12. BTG plc: Acquisition of EKOS

  13. BTG plc: Genzyme Receives Positive CHMP Opinion for LEMTRADA™ (alemtuzumab) in Europe

  14. BTG plc: Publication of Circular and Notice of General Meeting

  15. BTG to Present at the Jefferies Global Healthcare Conference

  16. BTG to Present at the 38th Annual Deutsche Bank Health Care Conference

  17. BTG plc: Results of Placing

  18. BTG plc: Proposed Acquisition of TheraSphere®

  19. BTG plc: Acquisition of EKOS Corporation

  20. BTG plc: Proposed Placing or Ordinary New Shares

  21. BTG plc: Final Results

  22. The BTG Cycle Challenge 2013

  23. BTG plc: Varisolve® NDA accepted for full review by FDA

  24. BTG plc: Close Period Update

  25. BTG to Present at the Citi Global Healthcare Conference

  26. BTG plc: Varisolve® NDA submitted to the FDA

  27. BTG plc: Interim Management Statement

  28. BTG to present at the 31st Annual J.P. Morgan Healthcare Conference